| Stereochemistry | ACHIRAL |
| Molecular Formula | C31H29ClFN5O3 |
| Molecular Weight | 574.045 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC1=CC2=C(C=C1NC(=O)\C=C\CN(C)C)C(NC3=CC(Cl)=C(OCC4=CC(F)=CC=C4)C=C3)=C(C=N2)C#N
InChI
InChIKey=NERXPXBELDBEPZ-RMKNXTFCSA-N
InChI=1S/C31H29ClFN5O3/c1-4-40-29-16-26-24(15-27(29)37-30(39)9-6-12-38(2)3)31(21(17-34)18-35-26)36-23-10-11-28(25(32)14-23)41-19-20-7-5-8-22(33)13-20/h5-11,13-16,18H,4,12,19H2,1-3H3,(H,35,36)(H,37,39)/b9-6+
| Molecular Formula | C31H29ClFN5O3 |
| Molecular Weight | 574.045 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Originator
Approval Year
Sourcing
PubMed
Patents
Sample Use Guides
HKI-357 (7f) was formulated in 0.5% methylcellulose and 2.0% polysorbate-80 (Tween-80) and adminstered orally (80mk/kg, 40 mg/kg or 10 mg/kg) once daily for 20 days
Route of Administration:
Oral
Cells were plated in 96-well tissue culture plates (3T3, 3T3/neu, 5000 cells/well; A431, SK-Br-3, BT474, MDA-MB-435, and SW620, 10,000 cells/well). The following day, dilutions of HKI-357 (0.5 ng/mlâ5 mkg/ml) were added, and cells were cultured for 2 days (6 days for BT474). Cell proliferation was determined using sulforhodamine B, a protein binding dye.
